Additional Effect of Luseogliflozin on Semaglutide in Nonalcoholic Steatohepatitis Complicated by Type 2 Diabetes Mellitus: An Open-Label, Randomized, Parallel-Group Study

INTRODUCTION: Untreated nonalcoholic fatty liver may progress to nonalcoholic steatohepatitis (NASH) and cirrhosis and induce hepatocellular carcinoma and liver failure. Type 2 diabetes mellitus (T2DM), often complicated with nonalcoholic fatty liver disease (NAFLD), is a driver of NAFLD progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyake, Teruki, Yoshida, Osamu, Matsuura, Bunzo, Furukawa, Shinya, Hirooka, Masashi, Abe, Masanori, Tokumoto, Yoshio, Koizumi, Yohei, Watanabe, Takao, Takeshita, Eiji, Sunago, Kotaro, Yukimoto, Atsushi, Watanabe, Kyoko, Miyazaki, Masumi, Kanzaki, Sayaka, Nakaguchi, Hironobu, Koizumu, Mitsuhito, Yamamoto, Yasunori, Kumagi, Teru, Hiasa, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076799/
https://www.ncbi.nlm.nih.gov/pubmed/35312970
http://dx.doi.org/10.1007/s13300-022-01239-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076799/
https://www.ncbi.nlm.nih.gov/pubmed/35312970
http://dx.doi.org/10.1007/s13300-022-01239-7

Ejemplares similares